These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 7148511)
21. The copper-controlled diet: current aspects of dietary copper restriction in management of copper metabolism disorders. Smithgall JM J Am Diet Assoc; 1985 May; 85(5):609-10. PubMed ID: 3886765 [No Abstract] [Full Text] [Related]
22. [The role of zinc in the initial treatment of Wilson's disease in children]. Cacić M; Percl M; Jadresin O; Kolacek S Lijec Vjesn; 2000 Mar; 122(3-4):77-81. PubMed ID: 10932534 [TBL] [Abstract][Full Text] [Related]
23. Fatal deterioration of Wilson's disease after institution of oral zinc therapy. Lang CJ; Rabas-Kolominsky P; Engelhardt A; Kobras G; Konig HJ Arch Neurol; 1993 Oct; 50(10):1007-8. PubMed ID: 8280286 [No Abstract] [Full Text] [Related]
24. Long-term exclusive zinc monotherapy in symptomatic Wilson disease: experience in 17 patients. Linn FH; Houwen RH; van Hattum J; van der Kleij S; van Erpecum KJ Hepatology; 2009 Nov; 50(5):1442-52. PubMed ID: 19731238 [TBL] [Abstract][Full Text] [Related]
25. Low-dose zinc administration as an effective Wilson's disease treatment. Najda J; Stella-Hołowiecka B; Machalski M Biol Trace Elem Res; 2001 Jun; 80(3):281-4. PubMed ID: 11508632 [TBL] [Abstract][Full Text] [Related]
26. Molecular genetics and zinc-copper interactions in human Wilson's disease and canine copper toxicosis. Brewer GJ; Yuzbasiyan-Gurkan V; Lee DY Prog Clin Biol Res; 1993; 380():129-45. PubMed ID: 8456122 [No Abstract] [Full Text] [Related]
27. [Treatment of Wilson's disease with Zincteral]. Kuczyńska-Zardzewiały A; Rodo M; Członkowska A Neurol Neurochir Pol; 1988; 22(3):211-5. PubMed ID: 3221958 [TBL] [Abstract][Full Text] [Related]
28. Effective treatment of Wilson's disease with oral zinc. Hoogenraad TU Arch Neurol; 1982 Oct; 39(10):672. PubMed ID: 7125987 [No Abstract] [Full Text] [Related]
29. [Perspective study on effect of gandou tablet I on biliary trace elements in treating hepatolenticular degeneration]. Hu WB; Yang RM Zhongguo Zhong Xi Yi Jie He Za Zhi; 2001 Jul; 21(7):507-9. PubMed ID: 12575394 [TBL] [Abstract][Full Text] [Related]
30. Treatment of Wilson's disease with zinc. II. Validation of oral 64copper with copper balance. Hill GM; Brewer GJ; Juni JE; Prasad AS; Dick RD Am J Med Sci; 1986 Dec; 292(6):344-9. PubMed ID: 3799705 [TBL] [Abstract][Full Text] [Related]
31. Kinetics of 64Copper in primary biliary cirrhosis. Janssens AR; Van den Hamer CJ Hepatology; 1982; 2(6):822-7. PubMed ID: 7141395 [No Abstract] [Full Text] [Related]
32. Treatment of Wilson's disease. Brewer GJ; Yuzbasiyan-Gurkan V; Young AB Semin Neurol; 1987 Jun; 7(2):209-20. PubMed ID: 3332455 [No Abstract] [Full Text] [Related]
33. Paradigm shift in treatment of Wilson's disease: zinc therapy now treatment of choice. Hoogenraad TU Brain Dev; 2006 Apr; 28(3):141-6. PubMed ID: 16466879 [TBL] [Abstract][Full Text] [Related]
34. [Copper in the feces--a marker for the effectiveness of zinc in the treatment of Wilson's disease]. Dastych M Z Gastroenterol; 1990 Aug; 28(8):389-91. PubMed ID: 2275259 [TBL] [Abstract][Full Text] [Related]
35. Treatment of Wilson's disease with zinc. VII. Protection of the liver from copper toxicity by zinc-induced metallothionein in a rat model. Lee DY; Brewer GJ; Wang YX J Lab Clin Med; 1989 Dec; 114(6):639-45. PubMed ID: 2592854 [TBL] [Abstract][Full Text] [Related]
36. Copper kinetics in liver disease. Smallwood RA; McIlveen B; Rosenoer VM; Sherlock S Gut; 1971 Feb; 12(2):139-44. PubMed ID: 5548560 [TBL] [Abstract][Full Text] [Related]